- Home
- RMBI vs GALT Comparison
RMBI vs GALT Comparison
Compare RMBI & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RMBI | GALT |
|---|---|---|
| Founded | 1887 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.0M | 297.0M |
| IPO Year | 2019 | 2008 |
Fundamental Metrics
Financial Performance| Metric | RMBI | GALT |
|---|---|---|
| Price | $15.56 | $3.47 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 71.9K | ★ 1.0M |
| Earning Date | 04-23-2026 | 05-15-2026 |
| Dividend Yield | ★ 3.85% | N/A |
| EPS Growth | 27.17 | ★ 36.84 |
| EPS | ★ 0.28 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $54.86 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.77 | $2.03 |
| 52 Week High | $16.59 | $7.13 |
Technical Indicators
Market Signals| Indicator | RMBI | GALT |
|---|---|---|
| Relative Strength Index (RSI) | 56.59 | 45.02 |
| Support Level | $14.10 | $2.30 |
| Resistance Level | $16.31 | $4.35 |
| Average True Range (ATR) | 0.60 | 0.49 |
| MACD | -0.00 | -0.18 |
| Stochastic Oscillator | 60.00 | 9.01 |
Price Performance
Historical ComparisonAbout RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a bank holding company. Along with its subsidiary, it is mainly engaged in attracting deposits from the general public, as well as brokered deposits, and investing those funds in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one- to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. It also obtains funds by utilizing Federal Home Loan Bank (FHLB) advances. These funds are generally invested in investment securities, including mortgage-backed and mortgage-related securities and agency and municipal bonds. The Group's primary market area includes Wayne and Shelby counties in Indiana and Shelby, Miami, and Franklin counties in Ohio.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.